GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Futura Medical PLC (LSE:FUM) » Definitions » Shares Outstanding (EOP)

Futura Medical (LSE:FUM) Shares Outstanding (EOP) : 301.41 Mil (As of Dec. 2023)


View and export this data going back to 2003. Start your Free Trial

What is Futura Medical Shares Outstanding (EOP)?

Shares outstanding are shares that have been authorized, issued, and purchased by investors and are held by them. Futura Medical's shares outstanding for the quarter that ended in Dec. 2023 was 301.41 Mil.

Futura Medical's quarterly shares outstanding increased from Jun. 2023 (299.07 Mil) to Dec. 2023 (301.41 Mil). It means Futura Medical issued new shares from Jun. 2023 to Dec. 2023 .

Futura Medical's annual shares outstanding increased from Dec. 2022 (288.13 Mil) to Dec. 2023 (301.41 Mil). It means Futura Medical issued new shares from Dec. 2022 to Dec. 2023 .


Futura Medical Shares Outstanding (EOP) Historical Data

The historical data trend for Futura Medical's Shares Outstanding (EOP) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Futura Medical Shares Outstanding (EOP) Chart

Futura Medical Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Shares Outstanding (EOP)
Get a 7-Day Free Trial Premium Member Only Premium Member Only 204.66 245.63 287.15 288.13 301.41

Futura Medical Semi-Annual Data
Jun14 Dec14 Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23
Shares Outstanding (EOP) Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 287.15 287.30 288.13 299.07 301.41

Competitive Comparison of Futura Medical's Shares Outstanding (EOP)

For the Biotechnology subindustry, Futura Medical's Shares Outstanding (EOP), along with its competitors' market caps and Shares Outstanding (EOP) data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Futura Medical's Shares Outstanding (EOP) Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Futura Medical's Shares Outstanding (EOP) distribution charts can be found below:

* The bar in red indicates where Futura Medical's Shares Outstanding (EOP) falls into.



Futura Medical Shares Outstanding (EOP) Calculation

Shares outstanding are shares that have been authorized, issued, and purchased by investors and are held by them. They have voting rights and represent ownership in the corporation by the person that holds the shares. They should be distinguished from treasury shares, which are shares held by the corporation itself, having no exercisable rights.

Shares outstanding can be calculated as either basic or fully diluted. The fully diluted shares outstanding count includes diluting securities, such as options, warrants or convertibles.

Please note: GuruFocus named Shares Outstanding (EOP) is the shares for that end of period. It is usually used to calculate balance sheet related items, such as Book Value per Share, etc. While Shares Outstanding (Diluted Average) and Shares Outstanding (Basic Average) are the weighted average shares over a period of time (a year, a quarter, or so). They are usually used to calculate income statement or cashflow statement related items, such as Earnings per Share (Diluted), etc.


Futura Medical  (LSE:FUM) Shares Outstanding (EOP) Explanation

A company may buy back shares or issue shares in any fiscal period. If a company buys back shares, we should observe that the total number of shares decline. If the company issues new shares, the number of shares outstanding increases.

Usually the presence of treasury shares and a history of buyback are good indicators that company has competitive advantage. But studies have shown that companies usually buy back at wrong time. Buying back shares below its intrinsic value increases value for remaining shareholders. Buying back overvalued shares destroys value for existing shareholders.


Be Aware

Warren Buffett looks for consistency and upward long term trend. Because of share repurchase it is possible for net earnings trend to differ from EPS trend. He preferred net income over EPS. The companies with durable competitive advantage companies report higher % net earnings to total revenues.

Important: If a company is showing net earnings history greater than 20% on total revenues, it is probably benefiting from a long term competitive advantage.

If net earnings is less than 10%, likely to be in a highly competitive business.


Futura Medical Shares Outstanding (EOP) Related Terms

Thank you for viewing the detailed overview of Futura Medical's Shares Outstanding (EOP) provided by GuruFocus.com. Please click on the following links to see related term pages.


Futura Medical (LSE:FUM) Business Description

Traded in Other Exchanges
Address
40 Occam Road, Surrey Technology Centre, Guildford, Surrey, GBR, GU2 7YG
Futura Medical PLC is a pharmaceutical company based on technology. The company manufactures drugs and is based in the United Kingdom. The company lays primary focus on topically applied pharmaceutical drugs and medical devices which are developed using a efficient and proprietary transdermal delivery technology, DermaSys. DermaSys is a versatile technology that can be customized to suit the specific active compound being used and the therapeutic indication. The company's products are used mainly for the treatment of erectile dysfunction and pain relief.

Futura Medical (LSE:FUM) Headlines

No Headlines